Elmind Capital, LP
35 holdingsFiling period: 2026-06-30Current AUM: $376.6Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | COGT | COGENT BIOSCIENCES INC | 1.17M | $45.3M | $39.1M | 10.39% | -- | 2026-06-30 |
| 2 | SNDX | SYNDAX PHARMACEUTICALS INC | 1.85M | $40.5M | $33.7M | 8.96% | -- | 2026-06-30 |
| 3 | CLDX | CELLDEX THERAPEUTICS INC NEW | 990.0K | $36.8M | $36.5M | 9.70% | +125.0K | 2026-06-30 |
| 4 | RLAY | RELAY THERAPEUTICS INC | 1.47M | $27.4M | $27.6M | 7.34% | +928.3K | 2026-06-30 |
| 5 | PCVX | VAXCYTE INC | 452.3K | $26.3M | $26.9M | 7.14% | +135.8K | 2026-06-30 |
| 6 | VERA | VERA THERAPEUTICS INC | 436.5K | $18.7M | $15.3M | 4.06% | -45,982 | 2026-06-30 |
| 7 | — | PHARVARIS N V | 525.8K | $18.2M | $18.2M | 4.83% | +50.0K | 2026-06-30 |
| 8 | VRDN | VIRIDIAN THERAPEUTICS INC | 984.9K | $18.1M | $20.9M | 5.56% | +450.0K | 2026-06-30 |
| 9 | CTMX | CYTOMX THERAPEUTICS INC. | 4.55M | $17.1M | $15.0M | 3.97% | -- | 2026-06-30 |
| 10 | TVTX | TRAVERE THERAPEUTICS INC | 292.6K | $16.6M | $19.4M | 5.14% | +115.0K | 2026-06-30 |
| 11 | LEGN | LEGEND BIOTECH CORP | 570.6K | $16.5M | $10.6M | 2.82% | -- | 2026-06-30 |
| 12 | BEAM | BEAM THERAPEUTICS INC | 476.3K | $16.3M | $11.4M | 3.03% | -- | 2026-06-30 |
| 13 | CGEM | CULLINAN THERAPEUTICS INC | 690.0K | $12.6M | $14.2M | 3.77% | +160.0K | 2026-06-30 |
| 14 | NRIX | NURIX THERAPEUTICS INC | 460.0K | $11.2M | $11.5M | 3.07% | -- | 2026-06-30 |
| 15 | KRYS | KRYSTAL BIOTECH INC | 22.0K | $8.2M | $7.6M | 2.03% | -- | 2026-06-30 |
| 16 | UTHR | UNITED THERAPEUTICS CORP DEL | 15.0K | $8.1M | $7.5M | 1.98% | -- | 2026-06-30 |
| 17 | SMMT | SUMMIT THERAPEUTICS INC | 493.8K | $7.2M | $8.7M | 2.30% | -- | 2026-06-30 |
| 18 | INSM | INSMED INC | 65.0K | $6.9M | $8.4M | 2.23% | -- | 2026-06-30 |
| 19 | BCRX | BIOCRYST PHARMACEUTICALS INC | 520.0K | $5.2M | $4.2M | 1.12% | -480,000 | 2026-06-30 |
| 20 | MBX | MBX BIOSCIENCES INC | 91.0K | $5.0M | $5.4M | 1.43% | -120,000 | 2026-06-30 |
| 21 | PTGX | PROTAGONIST THERAPEUTICS INC | 38.0K | $4.7M | $5.6M | 1.50% | -- | 2026-06-30 |
| 22 | — | UROGEN PHARMA LTD | 120.0K | $4.4M | $4.4M | 1.17% | -100,000 | 2026-06-30 |
| 23 | DBVT | DBV TECHNOLOGIES S A | 265.0K | $4.3M | $3.1M | 0.83% | -- | 2026-06-30 |
| 24 | ALMS | ALUMIS INC | 130.0K | $3.7M | $1.2M | 0.32% | -- | 2026-06-30 |
| 25 | SUPN | SUPERNUS PHARMACEUTICALS | 70.0K | $3.3M | $2.9M | 0.77% | +50.0K | 2026-06-30 |
← Scroll →
Page 1 of 2